Representative Jefferson Shreve (R-Indiana) recently bought shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on May 08th, the Representative disclosed that they had bought between $15,001 and $50,000 in UnitedHealth Group stock on April 7th. The trade occurred in the Representative's "CRT - STANDARD UNIT TRUST" account.
Representative Jefferson Shreve also recently made the following trade(s):
- Purchased $50,001 - $100,000 in shares of Chipotle Mexican Grill NYSE: CMG on 4/17/2025.
- Purchased $50,001 - $100,000 in shares of Applied Materials NASDAQ: AMAT on 4/17/2025.
- Purchased $15,001 - $50,000 in shares of Caterpillar NYSE: CAT on 4/17/2025.
- Sold $15,001 - $50,000 in shares of Lululemon Athletica NASDAQ: LULU on 4/17/2025.
- Purchased $15,001 - $50,000 in shares of Western Digital NASDAQ: WDC on 4/17/2025.
- Sold $15,001 - $50,000 in shares of Zoetis NYSE: ZTS on 4/17/2025.
- Purchased $15,001 - $50,000 in shares of Stryker NYSE: SYK on 4/17/2025.
- Purchased $15,001 - $50,000 in shares of NextEra Energy NYSE: NEE on 4/17/2025.
- Purchased $15,001 - $50,000 in shares of CSX NASDAQ: CSX on 4/17/2025.
- Purchased $15,001 - $50,000 in shares of Ross Stores NASDAQ: ROST on 4/17/2025.
UnitedHealth Group Stock Performance
Shares of UNH traded up $2.45 during trading hours on Wednesday, hitting $313.83. The company had a trading volume of 15,021,157 shares, compared to its average volume of 5,013,815. The firm has a market cap of $284.69 billion, a price-to-earnings ratio of 20.21, a PEG ratio of 1.37 and a beta of 0.56. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $309.10 and a 12 month high of $630.73. The business has a fifty day moving average of $482.53 and a 200-day moving average of $519.28.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period in the previous year, the business posted $6.91 earnings per share. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 2.68%. UnitedHealth Group's dividend payout ratio is currently 35.18%.
Hedge Funds Weigh In On UnitedHealth Group
A number of large investors have recently modified their holdings of the company. Banco BTG Pactual S.A. lifted its position in UnitedHealth Group by 67.8% in the 1st quarter. Banco BTG Pactual S.A. now owns 886 shares of the healthcare conglomerate's stock valued at $464,000 after acquiring an additional 358 shares in the last quarter. Dorsey & Whitney Trust CO LLC lifted its position in shares of UnitedHealth Group by 1.1% during the first quarter. Dorsey & Whitney Trust CO LLC now owns 45,632 shares of the healthcare conglomerate's stock valued at $23,900,000 after purchasing an additional 506 shares in the last quarter. Aspire Growth Partners LLC increased its stake in UnitedHealth Group by 32.6% in the 1st quarter. Aspire Growth Partners LLC now owns 1,387 shares of the healthcare conglomerate's stock valued at $726,000 after buying an additional 341 shares during the last quarter. GDS Wealth Management increased its position in shares of UnitedHealth Group by 9.4% during the first quarter. GDS Wealth Management now owns 25,325 shares of the healthcare conglomerate's stock valued at $13,264,000 after acquiring an additional 2,181 shares during the last quarter. Finally, Capital Analysts LLC grew its stake in UnitedHealth Group by 3.4% in the 1st quarter. Capital Analysts LLC now owns 11,427 shares of the healthcare conglomerate's stock valued at $5,986,000 after purchasing an additional 381 shares during the period. 87.86% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of research analysts have issued reports on UNH shares. Barclays decreased their target price on shares of UnitedHealth Group from $642.00 to $560.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Erste Group Bank cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. KeyCorp lowered their target price on UnitedHealth Group from $575.00 to $450.00 and set an "overweight" rating for the company in a report on Wednesday. Mizuho upped their price objective on UnitedHealth Group from $600.00 to $650.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Finally, Bank of America cut shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and reduced their price objective for the stock from $560.00 to $350.00 in a research note on Wednesday. Six analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $536.05.
Check Out Our Latest Analysis on UNH
About Representative Shreve
Jefferson Shreve (Republican Party) is a member of the U.S. House, representing Indiana's 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Shreve (Republican Party) is running for re-election to the U.S. House to represent Indiana's 6th Congressional District. He declared candidacy for the 2026 election.
Email editor@ballotpedia.org to notify us of updates to this biography.
Jefferson Shreve earned a bachelor's degree from Indiana University in 1989, a graduate degree from the University of London in 1998, and a graduate degree from Purdue University in 2003. Shreve's career experience includes working as a real estate executive.
Shreve was elected 7th District Vice Chairman of the Indiana Republican State Committee on January 17, 2018, and was re-elected on March 6, 2021. In 2020, he was selected as a district-level delegate to the 2020 Republican National Convention.
UnitedHealth Group Company Profile
(
Get Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.